5-Chloromethyl-3-(4-nitro-phenyl)-[1,2,4]oxadiazole, 97.0%, 5g

1-(1-isobutylcyclobutyl)methanamine, 95.0%, 5g

2-Cyano-5-(trifluoromethyl)pyridine, 98.0%, 5g

(2-(Pyrrolidin-1-ylsulfonyl)phenyl)boronic acid, 95.0%, 5g

3-Methoxy-4-cyclopropylbromobenzene, 95%, 1g

(2s,4r)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95+%, 100mg

8-Chloro-6,7-difluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 250mg

(2-Methylpyridin-3-yl)methanamine, 95.0%, 1g

Tert-butyl 5-amino-3-cyclopropyl-1H-pyrazole-1-carboxylate, 98%, 5g

METHYL 2-(BENZYLCARBAMOYL)ACETATE, 95.0%, 2g

2-Isocyanato-1-methoxy-4-(trifluoromethyl)benzene, 98%, 100mg

1-(3-Aminobenzenesulfonyl)piperidin-4-ol, 95%, 100mg

Natriumbutyrat, min. 98 %, zur Synthese, 250 g, kunststoffverpackung.